Article
The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage.
Experimental cell research - 1 Jan 2015
Wang Xuening, Pesakhov Stella, Harrison Jonathan S, Kafka Michael, Danilenko Michael, Studzinski George P
Abstract excerpt
Intracellular signaling pathways present targets for pharmacological agents with potential for treatment of neoplastic diseases, with some disease remissions already recorded. However, cellular compensatory mechanisms usually negate the initial success. For instance, attempts to interrupt aberrant signaling downstream of the frequently mutated ras by inhibiting ERK1/2 has shown only limited usefulness for cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
